Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2019 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Long-Term Debt Issuances of $8000.0 for Q1 2026, up 33.33% year-over-year from $6000.0 in Q1 2025, and up 33.33% quarter-over-quarter from $6000.0 in Q1 2025.
Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2019 - 2026) Analysis & Trends
Aquestive Therapeutics' Long-Term Debt Issuances history runs 6 years deep, the most recent figure standing at $8000.0 for Q1 2026.
- In Q1 2026, Long-Term Debt Issuances rose 33.33% year-over-year to $8000.0; the TTM figure through Mar 2026 stood at $14000.0 (down 99.63% YoY), while the FY2025 annual figure was $26000.0, up 13.04% from the prior year.
- Long-Term Debt Issuances for Q1 2026 stood at $8000.0, up from $6000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $9.1 million in Q1 2023, with the low at -$9.1 million in Q2 2023.
- The 4-year median for Long-Term Debt Issuances is $8000.0 (2026), against an average of $763800.0.
- The sharpest annual moves came in 2023 and 2026: Long-Term Debt Issuances tumbled 338.79% in 2023, then soared 33.33% in 2026.
- Aquestive Therapeutics' Long-Term Debt Issuances stood at $3.8 million in 2022, then sank by 338.79% to -$9.1 million in 2023, then jumped by 100.07% to $6000.0 in 2025, then jumped by 33.33% to $8000.0 in 2026.
- Business Quant data shows AQST's Long-Term Debt Issuances at $8000.0 in Q1 2026, $6000.0 in Q1 2025, and -$9.1 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | 54.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.33 Mn |
| Jun 30, 2026 | 54.33 Mn |
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Jun 30, 2023 | -9.09 Mn |
| Jun 30, 2023 | -9.09 Mn |
| Mar 31, 2023 | 9.09 Mn |
| Mar 31, 2023 | 9.09 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Dec 31, 2020 | 22.50 Mn |
| Dec 31, 2020 | 22.50 Mn |
| Sep 30, 2019 | 69.45 Mn |
| Sep 30, 2019 | 69.45 Mn |